Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book
  1. Brieflands
  2. journals
  3. Nephro-Urology Monthly
  4. Articles

  5. Mannose Binding Lectin Serum Level and Gene Polymorphism in Patients with SLE and Its Relation to the Development of Lupus Nephritis
  6. Scopus by Title (Ref)

Nephro-Urology Monthly

homeHome
play_arrowCurrent IssuelistAll Issuesformat_indent_increaseIn PresssearchSearchcheck_circleAccepted Manuscripts
settingsInstructions
bookmarkJournal InformationgroupsBoards and CommitteesshareIndexing and Listing SourcesbalancePublication Ethics and Malpractice StatementemailSupportassignment_indReviewer and AE Registration FormphoneContact Usshow_chartJournal Metricszoom_inOpen Peer Review (OPR)
format_list_bulletedAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Mannose binding lectin 2 promotor-221 X/Y gene polymorphism in Egyptian systemic lupus erythematosus patients

- Harraz E. , et al.

2. Mannose binding Lectin (MBL) and its clinical significance

- Asgharzadeh M. , et al.

3. MBL2 polymorphisms - manifestations in Bulgarian patients with adult dermatomyositis and systemic lupus erythematosus

- Hristova M. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • All Issues
  • In Press
  • Search
  • Accepted Manuscripts

About Journal

  • Journal Information
  • Boards and Committees
  • Indexing and Listing Sources
  • Publication Ethics and Malpractice Statement
  • Support
  • Reviewer and AE Registration Form
  • Contact Us
  • Journal Metrics
  • Open Peer Review (OPR)
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.